Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02329093
Other study ID # Hip OA Pro-Study 2015
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2021
Est. completion date November 2026

Study information

Verified date September 2021
Source Shinshu University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As we have previously reported, the primary cause of hip OA with accompanying joint pain might be bone alterations which can be microfracture. In order to prove it, it is planned that conservative treatment will be performed on the hip OA patients with accompanying joint pain for the first year. For the second year, if the patients still have joint pain, they will do non-weght bearing walk.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date November 2026
Est. primary completion date November 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Hip OA, Joint pain Exclusion Criteria: - Obvious radipgraphic fracture in hip joint,

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
To MRI-detecting bone signal changes in radiographic hip OA
To examine whether or not non-weight bearing reduced OA progression

Locations

Country Name City State
Japan Yukio Nakamura Matsumoto Nagano

Sponsors (1)

Lead Sponsor Collaborator
Shinshu University

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bone Signal Changes on the Hip MRI 1 - 2 years